Remove Clinical Research Remove Doctors Remove Genetics Remove Pharmacy
article thumbnail

Insights into Precision Dosing with Dr. Howard McLeod and Dr. Sharmeen Roy – Xtalks Life Science Podcast Ep. 163

XTalks

It leverages various patient-specific factors, including genetics, age, weight, organ function and even lifestyle, to determine the most appropriate dosage for each individual. Her career spans pediatric clinical pharmacy, clinical research and pharmacogenomics with leadership roles at University of Chicago Medical Center and PipelineRx.

article thumbnail

Drug development and working with specialised Rare Disease networks

pharmaphorum

Specialty sites are able to provide specific information on one Rare Disease or a particular group of Rare Diseases, as well as general information, such as details on treatments, as well as access to expert doctors and clinical research studies. The potential to leverage genomic data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A history of the pharmaceutical industry

pharmaphorum

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. Originating as a pharmacy founded in Darmstadt in 1668, it was in 1827 that Heinrich Emanuel Merck began the transition towards an industrial and scientific concern, by manufacturing and selling alkaloids.

Medicine 145
article thumbnail

Viagra ‘should be tested as Alzheimer’s therapy’

pharmaphorum

Scientists in the US have found that people who use Viagra for erectile dysfunction seem to have a lower risk of developing Alzheimer’s disease – a link that they say should be examined more closely in clinical trials. Sildenafil is also sold as Revatio to treat pulmonary artery hypertension (PAH).

Drugs 52
article thumbnail

COVID-19 Pandemic Coverage

XTalks

CanSino Biologics is developing a vaccine that involves snipping a bit of the virus’ genetic code off and coupling it with a harmless virus to provoke a SARS-CoV-2 immune response. Several laboratories have already shown that they can detect genetic material from the virus in wastewater.